178 related articles for article (PubMed ID: 20176056)
1. Transgenic mouse model integrating siRNA targeting the foot and mouth disease virus.
Pengyan W; Jianjun J; Ning L; Jinliang S; Yan R; Chuangfu C; Zhiru G
Antiviral Res; 2010 Aug; 87(2):265-8. PubMed ID: 20176056
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of in vitro inhibitory potential of small interfering RNAs directed against various regions of foot-and-mouth disease virus genome.
Mohapatra JK; Sanyal A; Hemadri D; Tosh C; Kumar RM; Bandyopadhyay SK
Biochem Biophys Res Commun; 2005 Apr; 329(3):1133-8. PubMed ID: 15752771
[TBL] [Abstract][Full Text] [Related]
3. Cross-inhibition to heterologous foot-and-mouth disease virus infection induced by RNA interference targeting the conserved regions of viral genome.
Liu M; Chen W; Ni Z; Yan W; Fei L; Jiao Y; Zhang J; Du Q; Wei X; Chen J; Liu Y; Zheng Z
Virology; 2005 May; 336(1):51-9. PubMed ID: 15866070
[TBL] [Abstract][Full Text] [Related]
4. RNA interference targeting VP1 inhibits foot-and-mouth disease virus replication in BHK-21 cells and suckling mice.
Chen W; Yan W; Du Q; Fei L; Liu M; Ni Z; Sheng Z; Zheng Z
J Virol; 2004 Jul; 78(13):6900-7. PubMed ID: 15194766
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of foot-and-mouth disease virus replication in vitro and in vivo by small interfering RNA.
Pengyan W; Yan R; Zhiru G; Chuangfu C
Virol J; 2008 Jul; 5():86. PubMed ID: 18652701
[TBL] [Abstract][Full Text] [Related]
6. Multiple shRNAs driven by U6 and CMV promoter enhances efficiency of antiviral effects against foot-and-mouth disease virus.
Kim SM; Lee KN; Lee SJ; Ko YJ; Lee HS; Kweon CH; Kim HS; Park JH
Antiviral Res; 2010 Sep; 87(3):307-17. PubMed ID: 20561543
[TBL] [Abstract][Full Text] [Related]
7. Transgenically mediated shRNAs targeting conserved regions of foot-and-mouth disease virus provide heritable resistance in porcine cell lines and suckling mice.
Jiao Y; Gong X; Du J; Liu M; Guo X; Chen L; Miao W; Jin T; Chang H; Zeng Y; Zheng Z
Vet Res; 2013 Jul; 44(1):47. PubMed ID: 23822604
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic application of RNA interference against foot-and-mouth disease virus in vitro and in vivo.
Kim SM; Lee KN; Park JY; Ko YJ; Joo YS; Kim HS; Park JH
Antiviral Res; 2008 Nov; 80(2):178-84. PubMed ID: 18601955
[TBL] [Abstract][Full Text] [Related]
9. Silencing of the foot-and-mouth disease virus internal ribosomal entry site by targeting relatively conserved region among serotypes.
Matsui T; Handa Y; Kanda T; Tsukiyama-Kohara K
Virus Genes; 2019 Dec; 55(6):786-794. PubMed ID: 31367998
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of foot-and-mouth disease virus infections in cell cultures with antisense morpholino oligomers.
Vagnozzi A; Stein DA; Iversen PL; Rieder E
J Virol; 2007 Nov; 81(21):11669-80. PubMed ID: 17728223
[TBL] [Abstract][Full Text] [Related]
11. Induction of protection against foot-and-mouth disease virus in cell culture and transgenic suckling mice by miRNA targeting integrin αv receptor.
Du J; Guo X; Gao S; Luo J; Gong X; Hao C; Yang B; Lin T; Shao J; Cong G; Chang H
J Biotechnol; 2014 Oct; 187():154-61. PubMed ID: 25016204
[TBL] [Abstract][Full Text] [Related]
12. Differences in the virulence of two strains of Foot-and-Mouth Disease Virus Serotype A with the same spatiotemporal distribution.
García-Nuñez S; König G; Berinstein A; Carrillo E
Virus Res; 2010 Jan; 147(1):149-52. PubMed ID: 19883705
[TBL] [Abstract][Full Text] [Related]
13. Adenovirus-mediated RNA interference against foot-and-mouth disease virus infection both in vitro and in vivo.
Chen W; Liu M; Jiao Y; Yan W; Wei X; Chen J; Fei L; Liu Y; Zuo X; Yang F; Lu Y; Zheng Z
J Virol; 2006 Apr; 80(7):3559-66. PubMed ID: 16537624
[TBL] [Abstract][Full Text] [Related]
14. [Rescue of bovine Asia 1 serotype foot-and-mouth disease virus from a full-length cDNA clone].
Li S; Zhang R; Song G; Gao M; Liu X; Wang J
Sheng Wu Gong Cheng Xue Bao; 2009 Nov; 25(11):1621-6. PubMed ID: 20222458
[TBL] [Abstract][Full Text] [Related]
15. Fluorescence-based multiplex real-time RT-PCR arrays for the detection and serotype determination of foot-and-mouth disease virus.
Tam S; Clavijo A; Engelhard EK; Thurmond MC
J Virol Methods; 2009 Nov; 161(2):183-91. PubMed ID: 19427333
[TBL] [Abstract][Full Text] [Related]
16. Rapid control of foot-and-mouth disease outbreaks: is RNAi a possible solution?
Grubman MJ; de los Santos T
Trends Immunol; 2005 Feb; 26(2):65-8. PubMed ID: 15668119
[No Abstract] [Full Text] [Related]
17. Short hairpin RNA targeted to the highly conserved 2B nonstructural protein coding region inhibits replication of multiple serotypes of foot-and-mouth disease virus.
de los Santos T; Wu Q; de Avila Botton S; Grubman MJ
Virology; 2005 May; 335(2):222-31. PubMed ID: 15840521
[TBL] [Abstract][Full Text] [Related]
18. Attenuated Salmonella choleraesuis-mediated RNAi targeted to conserved regions against foot-and-mouth disease virus in guinea pigs and swine.
Cong W; Jin H; Jiang C; Yan W; Liu M; Chen J; Zuo X; Zheng Z
Vet Res; 2010; 41(3):30. PubMed ID: 20167192
[TBL] [Abstract][Full Text] [Related]
19. Identification of short hairpin RNA targeting foot-and-mouth disease virus with transgenic bovine fetal epithelium cells.
Wang H; Wu J; Liu X; He H; Ding F; Yang H; Cheng L; Liu W; Zhong J; Dai Y; Li G; He C; Yu L; Li J
PLoS One; 2012; 7(8):e42356. PubMed ID: 22905125
[TBL] [Abstract][Full Text] [Related]
20. A novel bi-functional DNA vaccine expressing VP1 protein and producing antisense RNA targeted to 5'UTR of foot-and-mouth disease virus can induce both rapid inhibitory effect and specific immune response in mice.
Yang B; Lan X; Li X; Yin X; Li B; Han X; Li Y; Zhang Z; Liu J
Vaccine; 2008 Oct; 26(43):5477-83. PubMed ID: 18694793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
